NCT00286260

Levetiracetam for Painful Polyneuropathy

Double-blind, Randomised, Placebo-controlled Trial of the Effect of Levetiracetam on Painful Polyneuropathy

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Odense University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Polyneuropathy of different etiologies is often associated with pain. The standard treatment of this pain is anticonvulsants or antidepressants, but none of these treatment are effective or tolerable for all patients. Levetiracetam is a newer anticonvulsant and it is the hypothesis is that it could relieve neuropathic pain in polyneuropathy. This is a randomised, double-blind, placebo-controlled, cross-over trial on the effect of levetiracetam 3.000 mg/day on pain in polyneuropathy

Conditions

• Painful Polyneuropathy

Interventions

Type	Name	Description
DRUG	levetiracetam	Levetiracetam tablet 500 mg, daily dose titrated to 3000 mg, 6 weeks

Timeline

• Start date: 2006-01-01
• Primary completion: 2008-08-01
• Completion: 2008-10-01
• First posted: 2006-02-03
• Last updated: 2009-12-18

Locations

1 site across 1 country: Denmark